title: Reanalysis of cancer drugs: old drugs, new tricks.
authors.affiliation: Van Andel Research Institute, Grand Rapids, Michigan 49503, USA. george.vanderwoude@vai.org
authors.forename: George F
authors.initials: GF
authors.lastname: Vande Woude
authors.forename: Gary J
authors.initials: GJ
authors.lastname: Kelloff
authors.forename: Raymond W
authors.initials: RW
authors.lastname: Ruddon
authors.forename: Han-Mo
authors.initials: HM
authors.lastname: Koo
authors.forename: Caroline C
authors.initials: CC
authors.lastname: Sigman
authors.forename: J Carl
authors.initials: JC
authors.lastname: Barrett
authors.forename: Robert W
authors.initials: RW
authors.lastname: Day
authors.forename: Adam P
authors.initials: AP
authors.lastname: Dicker
authors.forename: Robert S
authors.initials: RS
authors.lastname: Kerbel
authors.forename: David R
authors.initials: DR
authors.lastname: Parkinson
authors.forename: William J
authors.initials: WJ
authors.lastname: Slichenmyer
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor